Intravesical Bacillus Calmette-Guérin (BCG) treatment's severe complications: A single institution review of incidence, presentation and treatment outcome

Intravesical Bacillus Calmette-Guérin (BCG) treatment's severe complications: A single institution review of incidence, presentation and treatment outcome

Objectives: Intravesical Bacillus Calmette-Guérin (BCG) treatment for superficial bladder cancer is interrupted in approximatively 8% of cases as a result of complications. The objective is to report the severe related complications of Bacillus Calmette-Guérin (BCG) following an intravesical instill...

Full description

Bibliographic Details
Main Authors: R. Waked, J. Choucair, N. Chehata, E. Haddad, G. Saliba
Format: Article
Language:English
Published: Elsevier 2020-05-01
Series:Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Subjects:
Mycobacterial infection
Intravesical Bacillus Calmette-Guérin
Bacillus Calmette-Guerin
Urothelial bladder cancer
Severe complication
Treatment protocol
Online Access:http://www.sciencedirect.com/science/article/pii/S2405579420300073

Internet

http://www.sciencedirect.com/science/article/pii/S2405579420300073

Similar Items